Gastroenterology
Volume 123, Issue 4 , Pages 1129-1134, October 2002

Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs☆☆

*Gastrointestinal Biology, Integrative Pharmacology, AstraZeneca R&D Mölndal, Mölndal, Sweden; and Nerve-Gut Research Laboratory, Department of Gastroenterology, Hepatology and General Medicine, Royal Adelaide Hospital and Department of Medicine, University of Adelaide, Adelaide, Australia

Received 14 March 2002; accepted 20 June 2002.

Abstract 

Background & Aims: Transient lower esophageal sphincter relaxations (TLESRs) are the major cause of gastroesophageal acid reflux, and are triggered by postprandial gastric distention. Stimulation of GABAB receptors potently inhibits triggering of TLESR by gastric loads. The functional similarity between GABAB and cannabinoid receptors (CBRs) prompted us to study the role of CBRs on mechanisms of gastric distention-induced TLESRs. Methods: Gastric nutrient infusion and air insufflation was performed during gastroesophageal manometry in conscious dogs. The effects of the CBR agonist WIN 55,212-2 were assessed alone and in combination with the CBR1 antagonist SR141716A or the CBR2 antagonist SR144528. The effects of WIN 55,212-2 were also studied on firing of gastric vagal mechanosensitive afferents in an isolated preparation of ferret stomach. Results: WIN 55,212-2 (57 nmol/kg) inhibited the occurrence of TLESR after gastric loads by 80% (P < 0.01). The latency to the first TLESR after the load was prolonged (P < 0.001), and the occurrence of swallowing was reduced (P < 0.05). The CBR1 antagonist SR141716A reversed the effects of WIN 55,212-2, whereas the CBR2 antagonist SR144528 did not. The CBR1 antagonist alone increased occurrence of TLESR (P < 0.05). The responses of gastric vagal mechanoreceptors to distention were unaffected by WIN 55,212-2 at a concentration of 3 μmol/L. Conclusions: Exogenous and endogenous activation of the CBR1 receptor inhibits TLESRs. The effects of CBR1 are not mediated peripherally on gastric vagal afferents, and therefore are most likely in the brain stem.

GASTROENTEROLOGY 2002;123:1129-1134

Abbreviations:  CBR , cannabinoid receptor, GERD , gastroesophageal reflux disease, LES , lower esophageal sphincter, TLESR , transient lower esophageal sphincter relaxation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Address requests for reprints to: Anders Lehmann, Ph.D., Gastrointestinal Biology, Integrative Pharmacology, AstraZeneca R&D Mölndal, S-431 83 Mölndal, Sweden. e-mail Anders.Lehmann@astrazeneca.com; fax: (46) 31 776 3747.

☆☆ Supported by AstraZeneca R&D Mölndal.

PII: S0016-5085(02)00218-4

doi:10.1053/gast.2002.36025

Gastroenterology
Volume 123, Issue 4 , Pages 1129-1134, October 2002